INTERCEPT PHARMACEUTICALS IN

CUSIP: 45845P108 Class: Common Stock

STIFEL FINANCIAL CORP's Holding History (CIK: 0000720672)

Note: Option positions (PUT/CALL) are excluded.

Q2 2023
Shares 11,264 Value ($000) $125 Avg Close — Range —
Q2 2022
Shares 14,691 Value ($000) $203 Avg Close — Range —
Q1 2022
Shares 11,347 Value ($000) $185 Avg Close — Range —
Q4 2020
Shares 17,104 Value ($000) $422 Avg Close — Range —
Q3 2020
Shares 6,949 Value ($000) $288 Avg Close — Range —
Q2 2020
Shares 7,526 Value ($000) $361 Avg Close — Range —
Q4 2019
Shares 2,698 Value ($000) $333 Avg Close — Range —
Q3 2019
Shares 4,842 Value ($000) $322 Avg Close — Range —
Q1 2019
Shares 2,329 Value ($000) $258 Avg Close — Range —
Q4 2018
Shares 2,268 Value ($000) $228 Avg Close — Range —
Q2 2015
Shares 1,193 Value ($000) $288 Avg Close — Range —
Q1 2015
Shares 1,228 Value ($000) $347 Avg Close — Range —
Q4 2014
Shares 1,418 Value ($000) $221 Avg Close — Range —